Stay updated on Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Sign up to get notified when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study record content with a generic error page. This blocks access to the NCT02938520 study details.
    Difference
    20%
    Check dated 2026-09-23T00:07:17.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 to v3.7.0, representing a new version of the page for maintenance or updates.
    Difference
    0.0%
    Check dated 2026-09-16T00:08:31.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page now shows a new revision tag: v3.6.6, replacing the previous v3.6.5, indicating a backend/document revision without altering the displayed study details.
    Difference
    0.0%
    Check dated 2026-09-01T19:37:28.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    2016 ( U.S. NIH Grant/Contract ) was added to the study's identifiers. This indicates NIH funding associated with the trial, but it does not alter the study content or user actions.
    Difference
    0.0%
    Check dated 2026-08-25T20:51:21.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 was added and the previous revision v3.6.4 was removed from the revision records, updating the page's version history.
    Difference
    0.0%
    Check dated 2026-08-11T14:59:14.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The list of study locations now shows 108 sites across multiple countries, expanding from the prior 44 locations.
    Difference
    5%
    Check dated 2026-08-04T05:47:55.000Z thumbnail image

Stay in the know with updates to Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabotegravir/Rilpivirine for Virologic Suppression Clinical Trial page.